← All diseases
Brain and nervous system
Progressive supranuclear palsy (PSP)
Would you like to receive a message when new research about Progressive Supranuclear Palsy (PSP) is available? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there is new research on Progressive Supranuclear Palsy (PSP). View what Premium costs.
Publications (1027)
- Novel Conformation-Dependent Tau Antibodies Are Modulated by Adjacent Phosphorylation Sites. (2023/09/05) ♡
- Neurodegeneration: 2023 update. (2023/09/04) ♡
- Migraine and Tension-type Headache in Parkinson's Disease and Progressive Supranuclear Palsy/Corticobasal Syndrome. (2023/09/01) ♡
- Clinical features of progressive supranuclear palsy. (2023/08/30) ♡
- Serum GDF-15 Levels in Patients with Parkinson's Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy. (2023/08/30) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. TANK-Binding Kinase 1 Mutation as a Rare Cause of Frontotemporal Dementia in a Mexican Patient: The First Case Report in a Tertiary Referral Hospital in Mexico. (2023/08/23) ♡
- A descriptive study of Parkinson disease and atypical parkinsonisms in the Annuals of the Pathological Autopsy Cases in Japan. (2023/08/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Analysis of positron emission tomography hypometabolic patterns and neuropsychiatric symptoms in patients with dementia syndromes. (2023/08/01) ♡
- Determinants of Astrocytic Pathology in Stem Cell Models of Primary Tauopathies. (2023/07/26) ♡
- Identification of optimal value of magnetic resonance planimetry and the parkinsonism index for the diagnosis of Parkinson's disease and progressive supranuclear palsy. (2023/07/20) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Amantadine-Induced Craniofacial Myoclonus: Distinctive Iatrogenic Dysarthria in Parkinson's Disease. (2023/07/14) ♡
- Clinicopathological features of progressive supranuclear palsy with asymmetrical atrophy of the superior cerebellar peduncle. (2023/06/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Lower Cranial Dystonia with Inflated Cheeks: A Case of Dystonic Respiratory Failure. (2023/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Changing perspectives on frontotemporal dementia: A review. (2023/06/01) ♡
- Pre-diagnostic cognitive and functional impairment in multiple sporadic neurodegenerative diseases. (2023/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Genotype-phenotype correlation in the spectrum of frontotemporal dementia-parkinsonian syndromes and advanced diagnostic approaches. (2023/05/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. CBD diagnostic criteria: exclusions as important as inclusions. (2023/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Globular glial tauopathy type II. (2023/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Study design challenges and strategies in clinical trials for rare diseases: Lessons learned from pantothenate kinase-associated neurodegeneration. (2023/03/08) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease. (2023/03/07) ♡
- Cell-Specific Dysregulation of Iron and Oxygen Homeostasis as a Novel Pathophysiology in PSP. (2023/03/01) ♡
- Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains. (2023/03/01) ♡
- The many faces of globular glial tauopathy: A clinical and imaging study. (2023/02/01) ♡
- The Lived Experiences of People with Progressive Supranuclear Palsy and Their Caregivers. (2023/02/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Effects of Palliative Care for Progressive Neurologic Diseases: A Systematic Review and Meta-Analysis. (2023/02/01) ♡
- Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction are Altered in Parkinson's Disease and Related Disorders. (2023/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The effect of antidepressant therapy on a patient with progressive supranuclear palsy accompanied by depression, anxiety and fluctuating dementia. (2023/02/01) ♡
- Using Downgaze Palsy Progression Rate to Model Survival in Progressive Supranuclear Palsy-Richardson Syndrome. (2023/02/01) ♡
- Non-motor symptoms in multiple system atrophy: A comparative study with Parkinson's disease and progressive supranuclear palsy. (2023/01/23) ♡
- Two pathways differentially linking tau depositions, oxidative stress, and neuronal loss to apathetic phenotypes in progressive supranuclear palsy. (2023/01/15) ♡
- Pathological tau signatures and nuclear alterations in neurons, astrocytes and microglia in Alzheimer's disease, progressive supranuclear palsy, and dementia with Lewy bodies. (2023/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Additive value of [(18)F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome. (2023/01/01) ♡
- Performance of [(18)F]RO948 PET, MRI and CSF neurofilament light in the differential diagnosis of progressive supranuclear palsy. (2023/01/01) ♡
- Oligomeric α-synuclein and tau aggregates in NDEVs differentiate Parkinson's disease from atypical parkinsonisms. (2023/01/01) ♡
- Could hyperlipidemia be a risk factor for corticobasal syndrome? - a pilot study. (2023/01/01) ♡
- microRNA and circRNA in Parkinson's Disease and atypical parkinsonian syndromes. (2023/01/01) ♡
- Asymmetric Cerebral Peduncle Atrophy: A Simple Diagnostic Clue for Distinguishing Frontotemporal Lobar Degeneration from Alzheimer's Disease. (2023/01/01) ♡
- rs56405341 Variant Associates with Expression of C4orf33 and C4orf33 Was Downregulated in Alzheimer's Disease and Progressive Supranuclear Palsy. (2023/01/01) ♡
- Emerging evidence for dysregulated proteome cargoes of tau-propagating extracellular vesicles driven by familial mutations of tau and presenilin. (2023/01/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cerebral Tau Deposition in Comorbid Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis: An [18F]-Flortaucipir and 7T MRI Study. (2023/01/01) ♡
- Altered localization of nucleoporin 98 in primary tauopathies. (2022/12/22) ♡
- Differences in Striatal Metabolism in [(18)F]FDG PET in Parkinson's Disease and Atypical Parkinsonism. (2022/12/20) ♡
- Isolated Jaw and Tongue Tremor in a Definite Case of Progressive Supranuclear Palsy. (2022/12/20) ♡
- Hexameric Aggregation Nucleation Core Sequences and Diversity of Pathogenic Tau Strains. (2022/12/19) ♡
- Plasma sphingolipid abnormalities in neurodegenerative diseases. (2022/12/16) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial: Genotype-phenotype correlations in neurodegenerative diseases: From clinical features to neuroimaging signatures. (2022/12/16) ♡
- Reflexive and volitional saccadic eye movements and their changes in age and progressive supranuclear palsy. (2022/12/15) ♡
- Rapidly Progressive Corticobasal Degeneration Mimicking Brainstem Encephalitis. (2022/12/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Progressive Supranuclear Palsy Syndrome Associated With a Novel Tauopathy: Case Study. (2022/12/12) ♡
- Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using (31)P-MRSI. (2022/12/12) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.